©The Author(s) 2017.
World J Gastroenterol. Aug 7, 2017; 23(29): 5324-5332
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5324
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5324
Table 1 Demographic features of study subject n (%)
| Characteristics | UC patients | Non IBD control |
| No. of patients (total) | 8 | 8 |
| Sex (M/F) | 3/5 | 2/6 |
| Age (mean ± SD, range, yr) | 39.75 ± 10.29 (25-62) | 40.75 ± 11.86 (24-60) |
| Disease duration (mean ± SD, Range, yr) | 6.35 ± 6.52 (1.5-21) | NA |
| Disease extent | ||
| Proctitis | 3 (37.5) | |
| Left sided colitis | 5 (62.5) | |
| Medication | ||
| Mesalamine | 5 (62.5) | 0 |
| Azathioprine | 3 (37.5) | 0 |
| Steroids | 0 | 0 |
- Citation: Valmiki S, Ahuja V, Paul J. MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients. World J Gastroenterol 2017; 23(29): 5324-5332
- URL: https://www.wjgnet.com/1007-9327/full/v23/i29/5324.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i29.5324